Diclofenac sodium
USP/1188800 - United States Pharmacopeia (USP) Reference Standard
Synonym: Diclofenac sodium salt; 2-
CAS Number: 15307-79-6
Empirical Formula (Hill Notation): C14H10Cl2NNaO2
Molecular Weight: 318.13
MDL Number: MFCD00082251
Linear Formula: C14H10Cl2NNaO2
Product Type: Chemical
API family | diclofenac |
application(s) | pharmaceutical (small molecule) |
format | neat |
grade | pharmaceutical primary standard |
InChI | 1S/C14H11Cl2NO2.Na/c15-10 |
InChI key | KPHWPUGNDIVLNH-UHFFFAOYSA |
manufacturer/tradename | USP |
SMILES string | [Na+].[O-]C(=O)Cc1ccccc1N |
Analysis Note: | These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. |
Application: | Diclofenac sodium USP reference standard suitable for use in specified USP compendial quality tests and assays. Also used to prepare acid stage standard, standard, standard stock, sensitivity, and system suitability solution for the assay, impurity analysis, identification, and performance test by using liquid chromatography coupled with UV detector according to the given below monographs of United States Pharmacopeia (USP): • Diclofenac Sodium • Diclofenac Sodium Delayed-Release Tablets • Diclofenac Sodium Extended-Release Tablets • Diclofenac Sodium Topical Solution • Diclofenac Sodium and Misoprostol Delayed-Release Tablets |
Biochem/physiol Actions: | Standard NSAID and cyclooxygenase (COX) inhibitor. Major metabolites are 4´-hydroxydiclofenac and 5´-hydroxydiclofenac. Has been used as substrate selective for CYP2C9. |
General description: | Diclofenac sodium is a sodium salt of diclofenac, a non-steroidal anti-inflammatory drug (NSAID). It prevents the synthesis of prostaglandin involved in pain, inflammation, and fever by inhibiting the cyclooxygenase enzyme activity. |
General description: | This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia . |
Other Notes: | Sales restrictions may apply. |
Symbol | GHS06,GHS08,GHS09 |
Signal word | Danger |
Hazard statements | H301 - H361d - H372 - H411 |
Precautionary statements | P201 - P202 - P260 - P264 - P273 - P301 + P310 |
RIDADR | UN 2811 6.1 / PGIII |
WGK Germany | WGK 3 |
Flash Point(F) | Not applicable |
Flash Point(C) | Not applicable |
UNSPSC | 41116107 |